We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$22.1B
1-Year Est. Return
45.54%
This Fund
S&P 500
This Quarter
Est. Return
+9.69%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
–
AUM
$13.7B
AUM Growth
-$178M
(-1.3%)
Cap. Flow
-$1.14B
Cap. Flow
% of AUM
-8.27%
Top 10 Holdings %
Top 10 Hldgs %
25.57%
Holding
3,040
New
254
Increased
776
Reduced
1,044
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$14.9M |
| 2 |
Palo Alto Networks
PANW
|
+$14.8M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$9.08M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$7.73M |
| 5 |
Crown Holdings
CCK
|
+$5.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$901M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$71.6M |
| 3 |
Apple
AAPL
|
+$11.2M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$10.7M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$8.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.03% |
| 2 | Healthcare | 12.56% |
| 3 | Financials | 11.14% |
| 4 | Consumer Discretionary | 11.03% |
| 5 | Industrials | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Agios Pharmaceuticals
AGIO
$1.98B
| $823K | 0.01% |
29,063
+598
| +2% | +$14.9K |
|
1377
Viking Therapeutics
VKTX
$3.87B
| $822K | 0.01% |
+50,697
| New | +$1.06M |
|
1378
Ameresco
AMRC
$1.47B
| $821K | 0.01% |
16,887
+250
| +2% | +$11.3K |
|
1379
International Seaways
INSW
$4.82B
| $819K | 0.01% |
21,430
-4,049
| -16% | -$155K |
|
|
AVDX
1380
DELISTED
AvidXchange
AVDX
| $819K | 0.01% |
78,855
| – | – |
|
1381
Talos Energy
TALO
$2.63B
| $819K | 0.01% |
59,013
+23,500
| +66% | +$316K |
|
1382
Celldex Therapeutics
CLDX
$3.28B
| $817K | 0.01% |
24,073
+349
| +1% | +$11.8K |
|
1383
Under Armour
UAA
$2.29B
| $816K | 0.01% |
113,082
-2,626
| -2% | -$21.1K |
|
1384
Northwest Natural Holdings
NWN
$2.14B
| $815K | 0.01% |
18,928
+1,012
| +6% | +$45.7K |
|
|
VTYX
1385
DELISTED
Ventyx Biosciences
VTYX
| $815K | 0.01% |
24,841
+11,815
| +91% | +$407K |
|
1386
Strategic Education
STRA
$1.84B
| $814K | 0.01% |
11,993
| – | – |
|
1387
Andersons Inc
ANDE
$2.24B
| $811K | 0.01% |
17,581
| – | – |
|
|
CVSA
1388
Covista Inc
CVSA
$4.48B
| $807K | 0.01% |
23,495
+437
| +2% | +$17.5K |
|
|
SWTX
1389
DELISTED
SpringWorks Therapeutics
SWTX
| $806K | 0.01% |
30,736
+11,939
| +64% | +$314K |
|
|
VSTO
1390
DELISTED
Vista Outdoor Inc.
VSTO
| $806K | 0.01% |
29,114
| – | – |
|
1391
Enerpac Tool Group
EPAC
$1.88B
| $805K | 0.01% |
29,811
-1,461
| -5% | -$37.1K |
|
1392
Braze
BRZE
$3.3B
| $803K | 0.01% |
+18,348
| New | +$624K |
|
1393
PROG Holdings
PRG
$1.71B
| $803K | 0.01% |
24,993
-1,356
| -5% | -$40.9K |
|
|
GTY
1394
Getty Realty Corp
GTY
$2.06B
| $802K | 0.01% |
23,701
+1,690
| +8% | +$57.5K |
|
1395
MasterBrand
MBC
$1.86B
| $802K | 0.01% |
68,919
+64,515
| +1,465% | +$619K |
|
|
NVEE
1396
DELISTED
NV5 Global
NVEE
| $796K | 0.01% |
28,736
| – | – |
|
1397
WesBanco
WSBC
$4.09B
| $792K | 0.01% |
30,934
+888
| +3% | +$23.1K |
|
1398
ePlus
PLUS
$2.32B
| $792K | 0.01% |
14,062
+271
| +2% | +$13.3K |
|
1399
Atlanta Braves Holdings Series B
BATRK
$3.44B
| $792K | 0.01% |
19,979
| – | – |
|
|
BWIN
1400
Baldwin Insurance Group
BWIN
$2.92B
| $790K | 0.01% |
31,885
| – | – |
|
Similar funds
BA
FAM
VARA
CHP
EIM
HHII
MetLife Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, MetLife Investment Management held 3,040 positions worth $13.7B, down 1.3% from $13.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
MetLife Investment Management withdrew a net $1.14B in Q2 2023, closing 100 positions and reducing 1,044 holdings. Its most notable exit was Evoqua Water Technologies Corp. Common Stock, an estimated $3.05M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
Against the trend, MetLife Investment Management opened a new position in Knife River worth $2.46M.
- MetLife Investment Management's largest Q2 2023 buy was Knife River: 56,478 shares worth $2.46M.
- MetLife Investment Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $14.9M increase.
- MetLife Investment Management's biggest Q2 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $901M.
- MetLife Investment Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $3.05M.
- MetLife Investment Management's ten largest holdings make up 26% of its $13.7B portfolio in Q2 2023.
- MetLife Investment Management opened 254 new positions and closed 100 in Q2 2023.
- MetLife Investment Management's portfolio value fell 1.3% quarter-over-quarter to $13.7B.
Based on MetLife Investment Management's 13F filing for Q2 2023, filed 10 Aug 2023.